-
What are womens preferences when it comes to frequency and characteristics of menstrual bleeding in relation to reproductive status and oral contraceptive use? Here are highlights from a 2002 survey.
-
Extending the traditional 21/7 regimen of several forms of hormonal contraception has captured the attention of research scientists, and results of their investigations may lead to new approved uses of birth control drugs.
-
For patients who are considering extended or continuous use of combined oral contraceptives (OCs), thorough counseling is an important aspect of ensuring success with the method.
-
No birth control pill has been marketed that has instructed a woman to take more than 21 consecutive pills that are hormonally active. The new pill, Seasonale, under review by the Food and Drug Administration at press time, will instruct women to take 84 consecutive pills.
-
Over-the-counter (OTC) status for emergency contraception has moved a step closer with the Washington, DC-based Womens Capital Corp.s April 2003 filing with the Food and Drug Administration (FDA) to switch its levonorgestrel drug Plan B from prescription to OTC status.
-
Because the use of barrier methods other than male condoms has decreased, contraceptive research has focused on finding an acceptable female-controlled method serving the dual function of protecting against pregnancy and HIV. The latest barrier method on the market, approved in March 2003, is the FemCap.
-
Coker Ross C. Anticancer potential of turmeric. Altern Med Alert 2003;6(9):104-108.
-
Stokes MJ. Black cohosh use in menopause. Altern Med Alert 2003;6(9):97-101.
-
Sasser H. Alcohol and breast cancer: A final answer? Altern Med Alert 2003;6(9):101-104.
-
Greenfield RH. Glucosamine and blood sugar. Altern Med Alert 2003;6(9):108.
